BlackRock Discloses Significant Stake in Elanco Animal Health
Ticker: ELAN · Form: SC 13G · Filed: Jan 29, 2024 · CIK: 1739104
| Field | Detail |
|---|---|
| Company | Elanco Animal Health Inc (ELAN) |
| Form Type | SC 13G |
| Filed Date | Jan 29, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, SC-13G, passive-investment
TL;DR
**BlackRock just confirmed a big stake in Elanco, signaling institutional confidence.**
AI Summary
BlackRock Inc. filed an SC 13G on January 29, 2024, disclosing its ownership of Elanco Animal Health Inc. common stock as of December 31, 2023. This filing indicates that BlackRock, a major institutional investor, holds a significant stake in Elanco, signaling its confidence in the animal health company. For investors, this matters because large institutional ownership can provide stability and a vote of confidence in the company's long-term prospects.
Why It Matters
This filing shows a major institutional investor, BlackRock, has a substantial position in Elanco, which can be seen as a positive signal for the company's stability and future outlook.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of institutional ownership and does not inherently present new risks, but rather confirms a significant investor's position.
Analyst Insight
An investor might view BlackRock's continued ownership as a positive sign, suggesting stability and potential long-term value in Elanco. It could prompt further research into Elanco's fundamentals and BlackRock's investment thesis.
Key Players & Entities
- BlackRock Inc. (company) — reporting person and institutional investor
- Elanco Animal Health Inc. (company) — subject company, issuer of the securities
- December 31, 2023 (date) — date of event requiring the filing
- January 29, 2024 (date) — filing date of the SC 13G
Forward-Looking Statements
- BlackRock will maintain a significant stake in Elanco Animal Health Inc. throughout 2024. (BlackRock Inc.) — medium confidence, target: December 31, 2024
FAQ
What type of filing is this document?
This document is an SC 13G filing, specifically designated as an initial filing under Rule 13d-1(b) as indicated by the 'X' in the appropriate box.
Who is the reporting person in this SC 13G filing?
The reporting person is BlackRock, Inc., as stated under '(1) Names of reporting persons. BlackRock, Inc.' on the cover page.
What is the name of the issuer whose securities are being reported?
The issuer is Elanco Animal Health Incorporated, as clearly stated under '(Name of Issuer)' on the Schedule 13G form.
What is the CUSIP number for the securities mentioned in this filing?
The CUSIP number for the common stock of Elanco Animal Health Incorporated is 28414H103, as listed on the Schedule 13G form.
What was the 'Date of Event Which Requires Filing of this Statement'?
The date of the event which required the filing of this statement was December 31, 2023, as specified on the Schedule 13G form.
Filing Details
This Form SC 13G (Form SC 13G) was filed with the SEC on January 29, 2024 regarding Elanco Animal Health Inc (ELAN).